-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SaQ10JB21Oq9sU+DQVMTNVdqi/wYeW/psR8m9akN0rShLI+NoDw/s5ITO2nTrRBc rj/XsaPsm2x6i+tsdK1GZA== 0001144204-07-007765.txt : 20070214 0001144204-07-007765.hdr.sgml : 20070214 20070214130125 ACCESSION NUMBER: 0001144204-07-007765 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070214 DATE AS OF CHANGE: 20070214 GROUP MEMBERS: FELIX J. BAKER SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ardea Biosciences, Inc./DE CENTRAL INDEX KEY: 0001103390 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943200380 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-59411 FILM NUMBER: 07617146 BUSINESS ADDRESS: STREET 1: 1009 OAK HILL ROAD STREET 2: SUITE 201 CITY: LAFAYETTE STATE: CA ZIP: 94549 BUSINESS PHONE: 650-845-6200 MAIL ADDRESS: STREET 1: 1009 OAK HILL ROAD STREET 2: SUITE 201 CITY: LAFAYETTE STATE: CA ZIP: 94549 FORMER COMPANY: FORMER CONFORMED NAME: INTRABIOTICS PHARMACEUTICALS INC /DE DATE OF NAME CHANGE: 20000127 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAKER JULIAN CENTRAL INDEX KEY: 0001087939 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: TISCH FAMILY INTERESTS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 212 521 2418 MAIL ADDRESS: STREET 1: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 SC 13D/A 1 v065916_sc13da.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) ARDEA BIOSCIENCES, INC. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.001 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 46116T 506 ---------------------------------------------------------------------- (CUSIP Number) Leo Kirby 667 Madison Avenue, 17th Floor New York, NY 10021 (212) 339-5633 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 31, 2006 ---------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. |_| Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 7 Pages SCHEDULE 13D - --------------------------------------- --------------------------------- CUSIP No. 46116T 506 Page 2 of 7 Pages ---------------- ----- ----- - --------------------------------------- --------------------------------- - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Julian C. Baker - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [_] (b) X - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) WC - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY EACH ---------------------------------------------------- REPORTING 8 SHARED VOTING POWER PERSON WITH 2,926,610 ---------------------------------------------------- 9 SOLE DISPOSITIVE POWER 0 ---------------------------------------------------- 10 SHARED DISPOSITIVE POWER 2,926,610 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,926,610 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 27.9% - -------------------------------------------------------------------------------- TYPE OF REPORTING PERSON (See Instructions) 14 IN - -------------------------------------------------------------------------------- Page 2 of 7 Pages SCHEDULE 13D - --------------------------------------- --------------------------------- CUSIP No. 46116T 506 Page 3 of 7 Pages --------------- ----- ------ - --------------------------------------- --------------------------------- - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Felix J. Baker - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [_] (b) X - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) WC - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 0 OWNED BY EACH ---------------------------------------------------- REPORTING 8 SHARED VOTING POWER PERSON WITH 2,926,610 ---------------------------------------------------- 9 SOLE DISPOSITIVE POWER 0 ---------------------------------------------------- 10 SHARED DISPOSITIVE POWER 2,926,610 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,926,610 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 27.9% - -------------------------------------------------------------------------------- TYPE OF REPORTING PERSON (See Instructions) 14 IN - -------------------------------------------------------------------------------- Page 3 of 7 Pages This Amendment No. 3 to Schedule 13D is being filed by Julian C. Baker and Felix J. Baker (the "Reporting Persons") to supplement the statements on Schedule 13D previously filed by them, as heretofore amended. Except as supplemented herein, such statements, as heretofore amended and supplemented, remain in full force and effect. Item 5. Interest in Securities of the Issuer. Set forth below is the aggregate number of shares of Common Stock held, including shares that maybe acquired upon conversion of Preferred Stock and shares that maybe acquired upon the exercise of Warrants and Options, as of the date hereof by each of the following, together with the percentage of outstanding shares of Common Stock that such number represents based upon 10,501,000 shares outstanding as reported on the Company's Form 10Q filed on November 7, 2006. Such percentage figures are calculated on the basis that the shares of Preferred Stock and Warrants owned by the Reporting Persons are deemed converted into or exercised for shares of Common Stock but other outstanding shares of Preferred Stock and Warrants are not deemed converted or exercised. Percent of class Name Number of Shares Outstanding ---- ---------------- ----------- Baker Bros. Investments, L.P. 91,337 0.9% Baker Bros. Investments II, L.P. 105,250 1.0% Baker Biotech Fund I , L.P. 1,099,807 10.5% Baker Brothers Life Sciences, L.P. 1,532,569 14.6% 14159, L.P. 19,140 0.1% Baker Tisch Investments, L.P. 78,507 0.8% Total 2,926,610 27.9% By virtue of their ownership of entities that have the power to control the investment decisions of the limited partnerships listed in the table above, Julian C. Baker and Felix J. Baker may each be deemed to be beneficial owners of shares owned by such entities and may be deemed to have shared power to vote or direct the vote of and shared power to dispose or direct the disposition of such securities. The following transactions in Common Stock were effected by the entities noted below during the sixty days preceding the filing of this statement. None of the reporting Persons has effected any other transactions in Common Stock during this period. Page 4 of 7 Pages
- ---------------------------------- -------------- ---------------- ---------------- -------- Number of Price/ Name Date Shares Transaction Share - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Tisch Investments, L.P. 12/22/2006 2,904 Purchase 3.8511 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Biotech Fund I, L.P. 12/22/2006 55,378 Purchase 3.8511 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Brothers Life Sciences, L.P. 12/22/2006 154,646 Purchase 3.8511 - ---------------------------------- -------------- ---------------- ---------------- -------- 14159, L.P. 12/22/2006 5,072 Purchase 3.8511 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Tisch Investments, L.P. 12/26/2006 1,558 Purchase 4.0000 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Biotech Fund I, L.P. 12/26/2006 29,722 Purchase 4.0000 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Brothers Life Sciences, L.P. 12/26/2006 82,998 Purchase 4.0000 - ---------------------------------- -------------- ---------------- ---------------- -------- 14159, L.P. 12/26/2006 2,722 Purchase 4.0000 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Tisch Investments, L.P. 1/9/2007 467 Purchase 4.7686 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Biotech Fund I, L.P. 1/9/2007 8,917 Purchase 4.7686 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Brothers Life Sciences, L.P. 1/9/2007 24,899 Purchase 4.7686 - ---------------------------------- -------------- ---------------- ---------------- -------- 14159, L.P. 1/9/2007 817 Purchase 4.7686 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Tisch Investments, L.P. 1/10/2007 333 Purchase 4.8300 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Biotech Fund I, L.P. 1/10/2007 6,351 Purchase 4.8300 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Brothers Life Sciences, L.P. 1/10/2007 17,735 Purchase 4.8300 - ---------------------------------- -------------- ---------------- ---------------- -------- 14159, L.P. 1/10/2007 581 Purchase 4.8300 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Tisch Investments, L.P. 1/11/2007 1,067 Purchase 5.2767 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Biotech Fund I, L.P. 1/11/2007 20,347 Purchase 5.2767 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Brothers Life Sciences, L.P. 1/11/2007 56,822 Purchase 5.2767 - ---------------------------------- -------------- ---------------- ---------------- -------- 14159, L.P. 1/11/2007 1,864 Purchase 5.2767 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Tisch Investments, L.P. 1/24/2007 223 Purchase 5.98440 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Biotech Fund I, L.P. 1/24/2007 4,242 Purchase 5.98440 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Brothers Life Sciences, L.P. 1/24/2007 11,847 Purchase 5.98440 - ---------------------------------- -------------- ---------------- ---------------- -------- 14159, L.P. 1/24/2007 388 Purchase 5.98440 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Tisch Investments, L.P. 1/25/2007 666 Purchase 6.0000 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Biotech Fund I, L.P. 1/25/2007 12,701 Purchase 6.0000 - ---------------------------------- -------------- ---------------- ---------------- -------- Baker Brothers Life Sciences, L.P. 1/25/2007 35,469 Purchase 6.0000 - ---------------------------------- -------------- ---------------- ---------------- -------- 14159, L.P. 1/25/2007 1,164 Purchase 6.0000 - ---------------------------------- -------------- ---------------- ---------------- -------- - ---------------------------------- -------------- ---------------- ---------------- --------
Page 5 of 7 Pages Exhibit 4. Agreement regarding the joint filing of this statement. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 14, 2007 By: /s/ Julian C. Baker ------------------------------ Julian C. Baker By: /s/ Felix J. Baker ------------------------------ Felix J. Baker Page 6 of 7 Pages EXHIBIT 4 AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, $0.001 par value, of Ardea Biosciences, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them. February 14, 2007 By: /s/ Julian C. Baker ----------------------------- Julian C. Baker By: /s/ Felix J. Baker ----------------------------- Felix J. Baker Page 7 of 7 Pages -----END PRIVACY-ENHANCED MESSAGE-----